The Petri Dish: Amylyx, Alnylam net drug approvals - Boston Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
DiaMedica Therapeutics Appoints Dr Kirsten Gruis as Chief Medical Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Executive with Extensive Track Record in Neurology and Rare Disease Drug DevelopmentMINNEAPOLIS (BUSINESS WIRE) DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointme.